2006;21(11):33
2006;21(11):33. how the cytotoxic medicines in ADCs are conjugated to antibodies arbitrarily, by cysteine or lysine residues. This generates heterogeneous ADC populations with 0 to 8 medicines per an antibody,…
Alternatively, blots were probed with goat anti-gp120 polyclonal antibody (US Biologicals catalog number H6003-35)
Alternatively, blots were probed with goat anti-gp120 polyclonal antibody (US Biologicals catalog number H6003-35). showed considerable deposition of DBPR112 IgG and C1q with post- but not pre-immune sera. These results…
It was because of a manifold of reasons [8]
It was because of a manifold of reasons [8]. Hence, in order to avoid potential reinfection and obtain global reduction of HCV attacks, a prophylactic vaccine is necessary. Recent vaccine…
Number 1 presents a schematic outlining the key features and methods for assembly of our manifestation construct
Number 1 presents a schematic outlining the key features and methods for assembly of our manifestation construct. in the manifestation of antibodies persist, hindering quick hit-to-lead identification. In particular, cloning…
Anderson J, McKay JA, Butcher RN
Anderson J, McKay JA, Butcher RN. of sheep and goats that's wide-spread in Africa, the center East, and Asia. Many effective vaccines Imexon can be found for the condition, predicated…
3, based on ELISA data (left panel) and antibody microarray data (right panel)
3, based on ELISA data (left panel) and antibody microarray data (right panel). disease-specific sensor (clinical immunoproteomics). Uniquely, the results showed that several biologically relevant proteins reflecting histological grade could…
The cells from the GT and cell-free supernatants from cultures with or with no supplementation of 3 M CuSO4 were analyzed by American blotting
The cells from the GT and cell-free supernatants from cultures with or with no supplementation of 3 M CuSO4 were analyzed by American blotting. activity was discovered through the conformational…
A general summary of latest applications from the developed electrochemical immunosensors in the clinical strategy is described
A general summary of latest applications from the developed electrochemical immunosensors in the clinical strategy is described. Keywords: clinical evaluation, electrochemistry, immunosensors, biomarker, label free of charge, labeled 1. described.…
Lymphocyte subsets were labeled and analyzed according to strategies described (6 previously, 18, 39C44)
Lymphocyte subsets were labeled and analyzed according to strategies described (6 previously, 18, 39C44). particular types of immune system cells as well as the proteins portrayed by these cells in…
Figure 6 shows the popularity of each drug as a first-, second- or third-line treatment following breakthrough relapses
Figure 6 shows the popularity of each drug as a first-, second- or third-line treatment following breakthrough relapses. Open in a separate window Fig. first collection MT (54.5%; 6/11). Treatment…
- Go to the previous page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- …
- 35
- Go to the next page